CardiomyopathiesUMBRELLANCT01561144
UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic Implantable Cardiac Defibrillator (ICD) Implant
An observational study of Cardiomyopathies and Cardiac Arrhythmias, run by Medtronic Cardiac Rhythm and Heart Failure at 51 sites in Spain.
Trial summary
The purpose of the study is to analyze the different patient profiles implanted with an Implantable Cardiac Defibrillator (ICD) in Spain (guidelines adoption) and the patient prognosis as a function of clinical profile, implant indication, arrhythmias incidence, treatments or device programming. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cardiomyopathies, Cardiac Arrhythmias, Cardiac Arrest
- How many people
- 4,648 participants
- Where
- 51 sitesSpain
- Study dates
- Aug 2011to Nov 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients inplanted with an Implantable Cardiac Defibrillator (ICD) according to guidelines.
Who may be able to join
- Patients with a Medtronic Implantable Cardiac Defibrillator (ICD) according to guidelines.
- Patients with CareLink home Telemonitoring System.
Who cannot join
- Unwillingness or inability to sign study written informed consent and/or CareLink consent.
Trial locations and contacts
51 sites in 1 country.
51 sites in 1 country
Spain51 sites
Complejo Hospitalario Universitario A Coruña
A Coruña
H. General de Alicante
Alicante
H. Universitario San Juan de Alicante
Alicante
Complejo Hospitalario Torrecárdenas de Almería
Almería
H. Universitario De La Ribera
Alzira, Valencia
H. Infanta Cristina
Badajoz
H. Universitari Germans Trias i Pujol
Badalona, Barcelona
H. de Cruces
Barakaldo, Vizcaya
H. Clinic I Provincial de Barcelona
Barcelona
H. de la Santa Creu i Sant Pau
Barcelona
H. de Basurto
Bilbao
H. Universitario de Burgos
Burgos
Complejo Hospitalario de Cáceres
Cáceres
H. San Pedro de Alcántara
Cáceres
H. Gral de Ciudad Real
Ciudad Real
H. Reina Sofía
Córdoba
Complejo Hospitalario Donostia
Donostia / San Sebastian, Guipúzcoa
H. General Universitario de Elche
Elche, Alicante
H. Galdakao - Usansolo
Galdakao, Vizcaya
H.Universitario Virgen de las Nieves
Granada
H.Universitario de Guadalajara
Guadalajara
H. Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona
H. Universitario Insular de las Palmas
Las Palmas de Gran Canaria
H. De León
León
H. Rafael Méndez
Lorca, Murcia
H. Clínico San Carlos
Madrid
H. Infanta Leonor
Madrid
H. Universitario 12 de Octubre
Madrid
H. Universitario Gregorio Marañón
Madrid
H. Universitario La Paz
Madrid
H. Universitario Ramón y Cajal
Madrid
H. Puerta de Hierro - Majadahonda
Majadahonda, Madrid
H. Clínico Virgen de la Victoria
Málaga
H. General Universitario Reina Sofía
Murcia
H. Universitario Virgen de la Arrixaca
Murcia
H. Universitario Central de Asturias
Oviedo, Principality of Asturias
H. Son Llátzer
Palma de Mallorca
H. de Navarra
Pamplona
H. Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife
H.Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife
H. Universitario Marqués de Valdecilla
Santander
Complejo Hospitalario de Santiago
Santiago de Compostela, Coruña
H. Universitario Nuestra Señora de Valme
Seville
H. Universitario Virgen Macarena
Seville
H. Universitario Joan XXIII
Tarragona
Complejo Hospitalario de Toledo
Toledo
H. General Universitario de Valencia
Valencia
H. Universitario la Fe
Valencia
H. Clínico Universitario de Valladolid
Valladolid
Complejo Hospitalario Universitario de Vigo
Vigo
H. de Txagorritxu
Vitoria-Gasteiz, Araba
About this study
Official title: UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic ICD Implant
The purpose of the study is to analyze the different patient profiles implanted with an Implantable Cardiac Defibrillator (ICD) in Spain (guidelines adoption) and the patient prognosis as a function of clinical profile, implant indication, arrhythmias incidence, treatments or device programming.
Read the detailed description
Umbrella is a prospective and retrospective cohort study.
- Conditions
- Cardiomyopathies, Cardiac Arrhythmias, Cardiac Arrest
- Keywords
- Defibrillators, Implantable, Cardiac arrhythmias, Heart Disease
- Medical subject headings
- Cardiomyopathies, Arrhythmias, Cardiac, Heart Arrest, Heart Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
To assess the number of ventricular and atrial arrhythmias, and atrial fibrillation burden detected by ICD.
Measured: End of the study, an expected duration of 5 years.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Mar 2012 (estimated)
- Study startAug 2011
- Primary completionNov 2017
- Study completionNov 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for CardiomyopathiesStudies of the same condition, open and under way.
- More trials run by Medtronic Cardiac Rhythm and Heart FailureThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 4,648 participants (actual)
Sponsor and investigators
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01561144
- Sponsor's protocol ID
- UMBRELLA
- Acronym
- UMBRELLA
- Status last verified
- Jun 2025
- First submitted
- 16 Mar 2012
- Last updated
- 8 Jul 2025
- Results posted
- No
Publications
Briongos-Figuero S, Garcia-Alberola A, Rubio J, Segura JM, Rodriguez A, Peinado R, Alzueta J, Martinez-Ferrer JB, Vinolas X, Fernandez de la Concha J, Anguera I, Martin M, Cerda L, Perez L; UMBRELLA Investigators *. Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results. J Am Heart Assoc. 2021 Jan 5;10(1):e018108. doi: 10.1161/JAHA.120.018108. Epub 2020 Dec 25.
PubMed 33356406Loughlin G, Datino T, Arenal A, Ruiz-Granell R, Sanchez-Gomez JM, Perez L, Martinez-Ferrer J, Alzueta J, Perez-Lorente F, Vinolas X, Fidalgo Andres ML, Fernandez de la Concha J. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies. Rev Esp Cardiol (Engl Ed). 2021 Apr;74(4):296-302. doi: 10.1016/j.rec.2020.06.017. Epub 2020 Aug 6. English, Spanish.
PubMed 32773348Lillo-Castellano JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, Alzueta J, Perez-Alvarez L, Alberola A, Fernandez-Lozano I, Rodriguez A, Porro R, Anguera I, Fontenla A, Gonzalez-Ferrer JJ, Canadas-Godoy V, Perez-Castellano N, Garofalo D, Salvador-Montanes O, Calvo CJ, Quintanilla JG, Peinado R, Mora-Jimenez I, Perez-Villacastin J, Rojo-Alvarez JL, Filgueiras-Rama D. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator. Heart. 2016 Oct 15;102(20):1662-70. doi: 10.1136/heartjnl-2016-309295. Epub 2016 Jun 13.
PubMed 27296239Anguera I, Dallaglio P, Martinez-Ferrer J, Rodriguez A, Alzueta J, Perez-Villacastin J, Porres JM, Vinolas X, Fontenla A, Fernandez-Lozano I, Garcia-Alberola A, Sabate X. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study. J Cardiovasc Electrophysiol. 2015 Jul;26(7):774-82. doi: 10.1111/jce.12699. Epub 2015 May 28.
PubMed 25916814
Study at a glance
From the registry record, last updated by the sponsor on 8 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- UMBRELLA - Incidence of Arrhythmias in Spanish Population With a Medtronic ICD Implant
- ClinicalTrials.gov ID
- NCT01561144
- Acronym / sponsor ID
- UMBRELLA / UMBRELLA
- Conditions
- Cardiomyopathies, Cardiac Arrhythmias, Cardiac Arrest
- Keywords
- Defibrillators, Implantable, Cardiac arrhythmias, Heart Disease
- Study type
- Observational
- Recruitment status
- Terminated
- Enrolment
- 4,648 participants (actual)
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart FailureIndustry (pharma, biotech, devices)
- Study start
- Aug 2011
- Primary completion
- Nov 2017 (actual)
- Study completion
- Nov 2017 (actual)
- First posted
- 22 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to analyze the different patient profiles implanted with an Implantable Cardiac Defibrillator (ICD) in Spain (guidelines adoption) and the patient prognosis as a function of clinical profile, implant indication, arrhythmias incidence, treatments or device programming.
Detailed description
Umbrella is a prospective and retrospective cohort study.
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients inplanted with an Implantable Cardiac Defibrillator (ICD) according to guidelines.
Key inclusion criteria (2 listed)
- Patients with a Medtronic Implantable Cardiac Defibrillator (ICD) according to guidelines.
- Patients with CareLink home Telemonitoring System.
Key exclusion criteria (1 listed)
- Unwillingness or inability to sign study written informed consent and/or CareLink consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
To assess the number of ventricular and atrial arrhythmias, and atrial fibrillation burden detected by ICD.
Time frame: End of the study, an expected duration of 5 years.
Results and safety
The study was stopped early. Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jul 2025.
- Derived from this study: PubMed 33356406Briongos-Figuero S, Garcia-Alberola A, Rubio J, Segura JM, Rodriguez A, Peinado R, Alzueta J, Martinez-Ferrer JB, Vinolas X, Fernandez de la Concha J, Anguera I, Martin M, Cerda L, Perez L; UMBRELLA Investigators *. Long-Term Outcomes Among a Nationwide Cohort of Patients Using an Implantable Cardioverter-Defibrillator: UMBRELLA Study Final Results. J Am Heart Assoc. 2021 Jan 5;10(1):e018108. doi: 10.1161/JAHA.120.018108. Epub 2020 Dec 25.
- Derived from this study: PubMed 32773348Loughlin G, Datino T, Arenal A, Ruiz-Granell R, Sanchez-Gomez JM, Perez L, Martinez-Ferrer J, Alzueta J, Perez-Lorente F, Vinolas X, Fidalgo Andres ML, Fernandez de la Concha J. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies. Rev Esp Cardiol (Engl Ed). 2021 Apr;74(4):296-302. doi: 10.1016/j.rec.2020.06.017. Epub 2020 Aug 6. English, Spanish.
- Derived from this study: PubMed 27296239Lillo-Castellano JM, Marina-Breysse M, Gomez-Gallanti A, Martinez-Ferrer JB, Alzueta J, Perez-Alvarez L, Alberola A, Fernandez-Lozano I, Rodriguez A, Porro R, Anguera I, Fontenla A, Gonzalez-Ferrer JJ, Canadas-Godoy V, Perez-Castellano N, Garofalo D, Salvador-Montanes O, Calvo CJ, Quintanilla JG, Peinado R, Mora-Jimenez I, Perez-Villacastin J, Rojo-Alvarez JL, Filgueiras-Rama D. Safety threshold of R-wave amplitudes in patients with implantable cardioverter defibrillator. Heart. 2016 Oct 15;102(20):1662-70. doi: 10.1136/heartjnl-2016-309295. Epub 2016 Jun 13.
- Derived from this study: PubMed 25916814Anguera I, Dallaglio P, Martinez-Ferrer J, Rodriguez A, Alzueta J, Perez-Villacastin J, Porres JM, Vinolas X, Fontenla A, Fernandez-Lozano I, Garcia-Alberola A, Sabate X. Shock Reduction With Multiple Bursts of Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators: A Multicenter Study. J Cardiovasc Electrophysiol. 2015 Jul;26(7):774-82. doi: 10.1111/jce.12699. Epub 2015 May 28.
Related trials for Cardiomyopathies
RecruitingObservational study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
Cardiomyopathies, Cardiac Arrest
Not yet recruiting
Human Experimental Models of Pain (HEMP)
Acute Pain
Active, not recruitingObservational study
A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Active, not recruiting
Assessment of Combined CCM and ICD Device in HFrEF
Heart Failure, Heart Failure With Reduced Ejection Fraction
Not yet recruiting
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices
Hypertrophic Cardiomyopathy, Left Ventricular Outflow Obstruction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
51 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiomyopathies and Cardiac Arrhythmias, run by Medtronic Cardiac Rhythm and Heart Failure at 51 sites in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 8 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 51 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early. Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To assess the number of ventricular and atrial arrhythmias, and atrial fibrillation burden detected by ICD. (time frame: End of the study, an expected duration of 5 years.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01561144, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2025.